4//SEC Filing
Rubin Marc 4
Accession 0000899243-20-001119
CIK 0001133416other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 6:01 PM ET
Size
5.6 KB
Accession
0000899243-20-001119
Insider Transaction Report
Form 4
Rubin Marc
Director
Transactions
- Award
Stock option (right to buy)
2020-01-09+30,000→ 30,000 totalExercise: $2.86Exp: 2030-01-09→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]The options were issued pursuant to the Galectin Therapeutics Inc. 2019 Omnibus Equity Incentive Plan.
- [F2]The options vest 100% on December 31, 2020.
Documents
Issuer
GALECTIN THERAPEUTICS INC
CIK 0001133416
Entity typeother
Related Parties
1- filerCIK 0001412377
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 6:01 PM ET
- Size
- 5.6 KB